Cite

HARVARD Citation

    Mailliez, A. et al. (2023). Diabetes is associated with high risk of severe adverse events during chemotherapy for cancer patients: A single‐center study. International journal of cancer. 152 (3), pp. 408-416. [Online]. 
  
Back to record